Cumberland Pharmaceuticals Inc (CPIX)

NASDAQ
3.05
-0.05(-1.61%)
After Hours
3.00
-0.05(-1.64%)
- Real-time Data
  • Volume:
    6,452
  • Bid/Ask:
    3.00/3.33
  • Day's Range:
    3.03 - 3.09

CPIX Overview

Prev. Close
3.1
Day's Range
3.03-3.09
Revenue
39.65M
Open
3.09
52 wk Range
2.58-3.94
EPS
-0.33
Volume
6,452
Market Cap
45.9M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
29,477
P/E Ratio
-
Beta
0.23
1-Year Change
-7.19%
Shares Outstanding
15,050,025
Next Earnings Date
Aug 17, 2021
What is your sentiment on Cumberland Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

Cumberland Pharmaceuticals Inc News

Cumberland Pharmaceuticals Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellSellSellSell
Technical IndicatorsBuyBuyStrong SellStrong BuyStrong Sell
SummaryNeutralNeutralStrong SellNeutralStrong Sell

Cumberland Pharmaceuticals Inc Company Profile

Cumberland Pharmaceuticals Inc Company Profile

Employees
90

Cumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren (ifetroban) Injection, and Boxaban (ifetroban) oral capsules for the treatment of patients with aspirin-exacerbated respiratory disease (AERD).

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.